Atomoxetine
Pricing Report NDC 66993-046-30

Latest NADAC: $0.94451 per EA · Effective Jun 22, 2022 · Est. package price $28.34 (30 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Atomoxetine (NDC 66993-046-30) is $0.94451 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 22, 2022.

As a provided by Prasco Laboratories, this medication is distributed in a 30 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.94451
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jun 22, 2022
Billable Units
30 EA
Estimated Package Price
$28.34
Data Status
As of Jun 22, 2022
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
66993-046-30
Description
30 CAPSULE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2017, the NADAC wholesale price for (NDC ) has moved within a range of $0.94451 to $4.06026 per EA. Over this 4 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.9445 - $4.0603
Market Volatility
329.88% Variance
Latest Trend
28.03%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jun 22, 2022 $0.94451 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 18, 2022 $1.31228 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 20, 2022 $1.32971 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 23, 2022 $1.76872 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 23, 2022 $1.33907 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 19, 2022 $1.87762 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 22, 2021 $1.43102 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 17, 2021 $1.46766 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 20, 2021 $1.76039 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 22, 2021 $2.24643 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 18, 2021 $2.32549 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 21, 2021 $1.68925 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026